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Abstract
Background: To form myelin oligodendrocytes expand and wrap their plasma membrane multiple
times around an axon. How is this expansion controlled?
Results: Here we show that cell surface area depends on actomyosin contractility and is regulated
by physical properties of the supporting matrix. Moreover, we find that chondroitin sulfate
proteoglycans (CSPG), molecules associated with non-permissive growth properties within the
central nervous system (CNS), block cell surface spreading. Most importantly, the inhibitory effects
of CSPG on plasma membrane extension were completely prevented by treatment with inhibitors
of actomyosin contractility and by RNAi mediated knockdown of myosin II. In addition, we found
that reductions of plasma membrane area were accompanied by changes in the rate of fluid-phase
endocytosis.
Conclusion: In summary, our results establish a novel connection between endocytosis, cell
surface extension and actomyosin contractility. These findings open up new possibilities of how to
promote the morphological differentiation of oligodendrocytes in a non-permissive growth
environment.
See related minireview by Bauer and ffrench-Constant: http://www.jbiol.com/content/8/8/78
Background
During their life cycle many cells undergo dramatic
changes in their cell morphology including rapid altera-
tions in shape and surface area. One way by which cells
change their surface area is to alter membrane traffic
between surface and interior. For example, loss of
integrin-mediated adhesion during tumor cell growth
triggers the rapid caveolin-mediated endocytosis that
leads to cell rounding [1-3]. Another example is the cell
surface area change that occurs during mitosis. At the
onset of mitosis the mother cell starts to round up, and
subsequently recovers when entering into anaphase.
These changes of plasma membrane area are regulated by
changes in endosomal membrane traffic [4].
A striking example of cell-shape change is the morpholog-
ical differentiation of oligodendrocytes during the devel-
opment of the central nervous system. First, small and
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bipolar oligodendrocyte precursor cells (OPCs) migrate
into the brain, where they differentiate into oligodendro-
cytes and expand their plasma membrane many folds in
order to wrap it several times around an axon [5,6]. In this
phase of myelination, each oligodendrocyte produces up
to ~50 × 103 μm2 of myelin surface membrane per day [7].
Since the generation of myelin occurs at the appropriate
time during neuronal development, it is assumed that
neuron-glia communication coordinates this process.
However, in cell culture oligodendrocytes differentiate
and extend large myelin membrane sheets in the absence
of neurons [8] indicating that the default action of oli-
godendrocytes is to differentiate. It is likely that in vivo
many different positive and negative signals from other
cells and the extracellular environment are integrated to
control proper and timely myelination. Previous studies
highlight the importance of extracellular matrix/integrin
interactions for the regulation of myelin-membrane sheet
extension [9]. Other studies have shown that the inactiva-
tion of the small Rho-GTPase, Rho A, is required for the
morphological differentiation of oligodendrocytes [10].
In addition, changes in membrane trafficking accompany
the growth of oligodendroglial cell surface area [11-14].
In this study, we tested how the extracellular environment
controls cell shape and membrane traffic in oligodendro-
glial cells.
Methods
Antibodies
The following primary antibodies were used: actin
(mouse monoclonal IgG, Sigma, St. Louis, MO), O1
(mouse monoclonal IgM), MBP (mouse monoclonal IgG;
Sternberger Inc., Lutherville, MD), nonmuscle myosin II
heavy chain A and B (polyconal Covance, Berkely, CA)
and betaIII-Tubulin (mouse monoclonal IgG, Sigma, St.
Louis, MO). Secondary antibodies were purchased from
Dianova (Hamburg, Germany).
Preparation of acrylamid gels on glass coverslips
To prepare acrylamid gels on glass coverslips and
crosslink adhesion proteins to the gels, we adapted the
protocol by [15]. Briefly, 18-mm-diameter glass coverslips
were incubated overnight in 0.1 N NaOH solution,
washed once with de-ionized water and dried on para-
film. Dry coverslips were covered with 100 μl of 3-APTMS
(3-aminopropyltrimethoxysilane, Sigma, St. Louis, MO)
for 3 min and thoroughly rinsed with de-ionized water.
Glass coverslips were then incubated in 0.5% glutaralde-
hyd (Sigma, St. Louis, MO) for 20 min at RT followed by
rinsing in de-ionized water. Coverslips were placed on
parafilm with the 3-APTMS coated side on top and dried.
Polyacrylamid gels were prepared by diluting 40% acryla-
mid 2K (AppliChem, Darmstadt, Germany) and 2% bis-
acrylamid 2K (AppliChem, Darmstadt, Germany) to final
concentrations of 7.5% acrylamid and 0.01% to 0.75%
bis-acrylamid in PBS pH 7.4. The polymerisation was
induced by adding 1.5 μl TEMED and 5 μl 10% ammo-
nium persulfate to 1000 μl of polyacrylamid solution. 30
μl of polyacrylamid solution was pipetted onto the centre
of the 18-mm-diameter 3-APTMS-coated coverslips and a
12-mm-diameter glass coverslip was placed on top of the
acrylamid solution. To allow complete polymerization
the gels were left at RT for 30 min before the top coverslip
was removed.
Crosslinking of adhesion proteins on polyacrylamid gels
To prevent polyacrylamid gels from drying, they were cov-
ered with 150 μl 1 mg/ml sulfo-SANPAH (Pierce, Rock-
ford, IL) immediately after polymerisation. The gels were
then places under an ultraviolet lamp at approximately 10
cm distance and irradiated for 10 min. The polyacrylamid
gels were immersed in 1 ml sterile 200 mM HEPES pH 8.6
in multi well plates (12 well, Cellstar, Greiner Bio-One).
The HEPES solution was aspirated and 1 ml 70% Ethanol
was added for 1 min to sterilize the polyacrylamid gels. To
remove residual ethanol and sulfo-SANPAH the gels were
washed overnight in 1 ml sterile 200 mM HEPES pH 8.6.
Coating with poly-L-lysine was done for 1 h at RT. The gels
were rinsed once with de-ionized water and dried for 10
min before plating with cells.
Cell culture and immunofluorescence
The oligodendroglial cell line, Oli-neu, was cultured on
poly-L-lysine as described previously [16]. Alternatively,
coverslips were coated with human fibronectin 10 μg/ml
(Millipore) overnight at +4°C. Primary cultures of oli-
godendrocytes were obtained from newborn mice and
cultured as described previously [17]. In brief, cells were
plated in MEM containing B27 supplement, 1% horse
serum, L-thyroxine, tri-iodo-thyronine, glucose,
glutamine, gentamycine, pyruvate, and bicarbonate on
poly-L-lysine coated glass coverslips after shaking. For
delivery of recombinant C3 transferase (Cytoskeleton,
Denver, CO) Chariot reagent (Active Motif, Carlsbad, CA)
was used according to the manufacturer's protocol and
cells were cultured for 10 h after protein transfection.
Alternatively, cells were treated with 10 μM of ROCK
inhibitor Y27632 (Calbiochem, Merck, Darmstadt, Ger-
many) or 50 μM of blebbistatin (Sigma Aldrich, Ger-
many) for 10 h at 37°C.
The effects of RGD-binding integrins were assessed by
treating Oli-neu cells for 8 h with 100 nM RGD-peptide
(#05231701, Calbiochem) or with the inactive control
RAD-peptide (#03340052, Calbiochem). Poly-L-lysine
pre-coated glass coverslips were incubated overnight at RT
in 10 ng/ml to 500 ng/ml Chondroitin sulfate proteogly-
cans (CSPGs) (Proteoglycan Mix, Millipore, Billerica,BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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MA), dried and rinsed with PBS before plating with cells.
Cells were plated in a density of 50 000 per 12 well (3.8
cm2).
siRNA nucleofection
Smart pool siRNA targeting myosin II-A, myosin II-B
(directed at the mouse sequences (accession numbers
NM_181327 and NM_175260, respectively) and of con-
trol non-targeting siRNA pool were purchased from Dhar-
macon (Dharmacon RNA Technologies, Lafayette, CO).
Electroporation was performed using the basic neuron
transfection Kit (Amaxa Biosystems, Cologne, Germany)
and Amaxa programm O-05 (Amaxa Biosystems,
Cologne, Germany) according to the manufacturer's pro-
tocol. Briefly, per transfection Oli-neu cells (2 × 106) were
harvested, resuspended in 100 μl resuspension buffer and
mixed with 160 pmol siRNA per transfection. The trans-
fection was repeated after 72 h. For electroporation of pri-
mary oligodendrocytes, 1.5 × 106 cells were collected,
nucleofected with both myosin II-A and II-B or control
siRNA and subsequently cultured for 3 d.
Cells were plated on coverslips and analysed for surface
extension and dextran uptake after another 24 h. Knock
down efficiency was controlled by western blot analysis
24 h or 48 h after the second transfection.
Endocytosis assays
Endocytosis was assessed by incubating Oli-neu cells for
15 or 30 min at 37°C with rhodamin-labelled Dextran
10K (Molecular Probes) in culture medium. Cells were
subsequently washed and fixed, followed by microscopic
analysis. Image processing and analysis was performed
using Meta Imaging Series 6.1 software (Universal Imag-
ing Corporation, West Chester, PA). For the quantifica-
tion of fluorescence intensities of internalized dextran a
fixed threshold was applied for all images. Immunofluo-
rescence was performed as described previously [11]. For
surface labelling with Alexa Fluor 488 conjugated wheat
germ agglutinin (WGA; Probes, Invitrogen, Carlsbad, CA)
fixed cells were incubated with WGA for 10 min at RT,
washed and mounted for microscopic analysis.
Microscopy and analysis
Fluorescence images were acquired using a Leica (Nuss-
loch, Germany) DMRXA microscope and a confocal laser
scanning microscope (TCS SP equipped with AOBS,
Leica) with 40× and 63× oil plan-apochromat objective
(Leica), respecively. Image processing and analysis was
performed using Meta Imaging Series 6.1 software (Uni-
versal Imaging Corporation). Quantification of fluores-
cence intensities was performed as described previously
[11]. The cell surface area of individual cells was approxi-
mated by measuring the projected area, the area covered
by the cell projected onto a single optical plane. The cells
analyzed were from at least 2 independent experiments.
Statistical differences were determined with Student's t
test.
Gel elasticity measurements
An atomic force microscope (AFM; NanoWizard, JPK
Instruments), mounted on a Zeiss Axiovert 200 M (Carl
Zeiss) was used to perform elasticity measurement. 5
micron diameter silica beads (Kisker) were attached to tip-
less cantilevers (MLCT, Veeco) using epoxy glue (Araldit).
Cantilever spring constants were determined using the
equipartition theorem. Polyacrylamide gels were probed
with a maximum indentation force of 1 nN at no less than
5 locations. Each indentation curve was fitted (Igor Pro,
Wavemetrics) according to the Hertz model [18] to obtain
the elasticity at each point.
Results
Regulation of cell surface area by the integrin binding 
RGD-peptide
We started assessing the influence of integrins on cell sur-
face area by treating the oligodendroglial cell line, Oli-
neu, with a monovalent integrin ligand (RGD-peptide) or
a non-binding control (RAD-peptide). Morphological
analysis of Oli-neu cells grown on fibronectin or poly-L-
lysine coated coverslips revealed a significant reduction in
cell surface area after treatment with RGD-peptide com-
pared to the inactive RAD-peptide (Figure 1A-C). Previous
results suggested that changes in the rate of endocytosis
control the extension of plasma membrane in Oli-neu
cells [12,13]. To elucidate whether the reduction of sur-
face area after the treatment with RGD-peptide was
accompanied by changes in the rate of endocytosis, we
analyzed fluid-phase endocytosis in Oli-neu cells, by stud-
ying the uptake of dextran. We found that treatment with
RGD-peptide resulted in a marked increase in fluid-phase
endocytosis (Figure 1D).
Signals from integrins to the Rho family GTPases regulates
morphological differentiation of oligodendrocytes [10].
We speculated that the contractile forces of the actomy-
osin cytoskeleton areimportant for the effect of the RGD-
peptide on oligodendrocytes. To test this hypothesis Oli-
neu cells were treated with inhibitors of the Rho/Rho-
kinase (ROCK) pathway (Y27632) and myosin II (bleb-
bistatin) blocking actomyosin contractility. We found
that treatment with either Y27632 or blebbistatin resulted
in a strong increase in cell surface area (Figure 1A, B).
Most importantly, the inhibitory effect of the RGD-pep-
tide on the cell size was completely abolished in cells
treated with blebbistatin and to a large extent in cells
treated with Y27632 suggesting that the RGD-peptide acts
by influencing actomyosin contractility. Taken together,
these experiments provide evidence that integrins are
involved in cell surface area control through a pathway
that is dependent on contractile forces within the cells.BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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Matrix rigidity and actomyosin contractility control cell 
surface area
There are number of recent studies demonstrating that
cells sense and response to the stiffness of their substrates
[19].
For example, matrix elasticity directs mesenchymal stem
cell lineage specification [20]. In addition, the branching
morphogenesis of neurons is modulated by physical
parameters in the microenvironment [21].
Since integrins in conjunction with actomyosin contractil-
ity are implicated in the sensing of these physical matrix
properties [22], we examined the influence of matrix
properties on cell surface expansion. The use of polyacry-
lamid gels with variable amounts of crosslinking bisacryl-
Integrins in cell surface expansion and endocytosis in Oli-neu cells Figure 1
Integrins in cell surface expansion and endocytosis in Oli-neu cells. (A) Oli-neu cells were treated for 8 h with 100 nM 
RGD-peptide, 100 nM inactive RAD-peptide, 10 μM Y27632 and 50 μM blebbistatin (blebb) as indicated. Cells were stained 
with Alexa Fluor 488 conjugated wheat germ agglutinin (green). Scale bar, 10 μm. (B) Changes in relative surface area were 
quantified by image analysis as described in Material and Methods. (C) Changes in relative surface area shown for cells grown 
on fibronectin. (D) Quantitative analysis of dextran uptake (30 min) in Oli-neu cells treated with 100 nM RGD-peptide or inac-
tive RAD-peptide for 8 h. Values represent means ± SEM (n > 70 cells, **p < 0,01; ***p < 0,001).BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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amid and covalently attached poly-L-lysine allowed the
physical properties of the matrix to be modulated
[21,15,23]. To ensure the use of matrices of physiological
rigidity their elastic modulus was measured by atomic
force microscopy. The values measured for the different
polyacrylamid gels varied within a physiological range
(Figure 2A). When Oli-neu cells were cultured on different
matrices, we observed a decrease in cell surface area on
soft matrices (Figure 2B, C). As previous results indicated
a connection between cell surface area and the rate of
endocytosis, we investigated the effects of matrix rigidity
on fluid phase endocytosis by measuring the uptake of
dextran. We found that the endocytosis of dextran
increased with decreasing matrix rigidity (Figure 2D, E),
again suggesting a relation between cell surface area and
fluid-phase endocytosis.
Next, we tested whether the inhibition of actomyosin con-
tractility influences the effects of matrix rigidity on cell
surface area. We observed that the inhibition of either
Rho/ROCK signaling by C3 transferase and Y27632 or
myosin II by blebbistatin restored cell surface expansion
on soft matrices (Figure 2F, G). When Oli-neu cells were
cultured on acrylamid gels in the presence of the RGD-
peptide, the cell surface area was reduced independent of
matrix rigidity, suggesting that integrins were required to
sense the physical properties of the matrix (Figure 2H).
However, after treatments with the RGD-peptide the cell
surface area was reduced to a larger extent on the softest
matrix (0.01% gels) as compared to matrices of medium
(0.07%) or harder (0,75%) consistence, suggesting addi-
tional integrin-independent mechanisms in the control of
membrane spreading.
By measuring the elastic modules of acrylamide gels with
atomic force microscopy, we ruled out that the RGD-pep-
tide affected matrix rigidity (the elastic module of 0.75%
gels was 7761 +/- 2200 in the presence of the RGD-pep-
tide).
Next, we investigated the effects of matrix rigidity on
membrane sheet expansion in primary oligodendrocytes.
Again, a considerable decrease in sheet size accompanied
decreasing matrix rigidity (Figure 3A, B).
Overcoming chondroitin sulfate proteoglycans inhibition 
of cell surface spreading by myosin II inhibition
One group of molecules that contribute to the non-per-
missive growth properties in the CNS environment are
chondroitin sulfate proteoglycans (CSPG) [24]. Studies
have implicated a role of the Rho kinase (ROCK) pathway
in CSPGs-mediated inhibition of neurite outgrowth [25].
We, therefore, determined the effects of CSPG on the sur-
face area of Oli-neu cells by plating the cells on different
concentrations of CSPG. We observed that the cell surface
area decreased with increasing concentration of CSPG.
The highest concentration of 500 ng CSPG resulted round
cells with diameters half that of control cells (Figure 4A,
B). Quantitative analysis revealed that in the presence of
Y27632, C3 transferase or blebbistatin the cell surface area
of Oli-neu cells did not change at CSPG concentrations of
up to 500 ng (Figure 4B, C).
Blebbistatin is a small molecule inhibitor with high affin-
ity and selectivity towards myosin II [26]. To confirm the
role of myosin IIA and/or IIB we used a siRNA knock-
down approach. Western blot analysis demonstrated the
efficient knock-down of both myosin IIA (Figure 5A) and
myosin IIB (Figure 5B). Knock-down of myosin IIA and
IIB promoted cell surface extension on CSPG. The strong-
est growth promoting effects were observed when both
myosins were reduced at the same time (Figure 5C).
To analyze whether the changes in cell surface area again
correlate with changes in fluid-phase endocytosis, we ana-
lyzed the rate of dextran uptake in Oli-neu cells cultured
on CSPG. We found that dextran was taken up more effi-
ciently with increasing concentrations of CSPG (Figure
5D). When cells were treated with either blebbistatin or
Y27632, the increase in fluid-phase endocytosis by CSPG
was completely prevented (Figure 5E). Furthermore, we
observed that the combined knock-down of myosin IIA
and IIB reduced fluid-phase uptake (Figure 5F).
Inhibition of actomyosin contractility promotes spreading 
of myelin-membrane sheets on a non-permissive substrate
Next, we used primary cultures of oligodendrocytes for
our experiments. These cells differentiate within a few
days from cells with multiple branches to myelin-mem-
brane sheet producing cells. In cell culture the differentia-
tion of oligodendrocytes follows a default pathway and
occurs in the absence of extrinsic signals from neuronal
cells.
When primary cells were treated with blebbistatin or
Y27632 cell surface area did not change significantly. We
analyzed whether growth on a non-permissive substrate
suppresses myelin-membrane extension and if so,
whether inhibition of actomyosin contractility could
overcome the block.
When primary oligodendrocytes were cultured on 500 ng
CSPG for 3 days (50 000 cells/3.8 cm2) there was a signif-
icant inhibition of membrane sheet extension (Figure
6A). The effect of the CSPG peptide was not observed to
the same extent when the cells were cultured at higher
density, indicating that unknown growth factors when
present in sufficient amounts are able to overcome the
inhibitory cues.BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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Matrix rigidity regulates cell surface area and endocytosis in Oli-neu cells Figure 2
Matrix rigidity regulates cell surface area and endocytosis in Oli-neu cells. (A) Quantification of the elastic shear 
moduli of polyacrylamid gels on glass coverslips with varying amounts of bisacrylamid. Values represent means ± SD (n > 30 
measurements). (B) Oli-neu cells were cultured for 1 d on polyacrylamid gels of different rigidities (using bisacrylamid varying 
from 0,5% to 0,01%) and analyzed for surface area differences by staining with Alexa Flour 488 conjugated wheat germ aggluti-
nin (green). Scale bar, 10 μm. (C) Quantification of the surface area of Oli-neu cells on polyacrylamid gels of different rigidities 
(mean ± SEM; n > 100 cells, ***p < 0,001). (D+E) Cells were cultured for 1 d on polyacrylamid gels of different rigidities by var-
ying the amount of bisacrylamid. Changes in the amount of dextran uptake ((D) 15 min and (E) 30 min) were quantified. Values 
represent the mean ± SEM (n > 60 cells from three independent experiments, ***p < 0,001). (F) Quantification of cell surface 
area of Oli-neu cells cultured on polyacrylamid gels for 1 d and treated for 10 h with 10 μM Y27632 or C3 transferase (mean 
± SEM; n > 100 cells, *p < 0,05, **p < 0,01, ***p < 0,001). (G) Quantitative analysis of surface area changes of Oli-neu cells cul-
tured for 1 d on polyacrylamid gels and treated with 50 μM blebbistatin (blebb) for 10 h (mean ± SEM; n > 60 cells, ***p < 
0,001). (H) Oli-neu cells were cultured on polyacrylamid gels of different rigidities, treated with RGD-peptide or inactive RAD-
peptide and changes in relative surface area were quantified. Values represent the mean ± SEM (n > 80 cells, *p < 0,05, **p < 
0,01, ***p < 0,001).BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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Next, we analyzed whether treatment with inhibitors to
block actomyosin contractility promoted the spreading of
membrane sheets on CSPG coated coverslips. Indeed,
inhibitors of the Rho/ROCK pathway and myosin II were
able to almost completely overcome the inhibition of cell
surface expansion induced by CSPG (Figure 6A).
To confirm the role of myosin IIA and/or IIB we per-
formed siRNA knock-down experiments in primary cells.
Knock-down of myosin IIA and IIB promoted cell surface
extension on CSPG as observed for Oli-neu cells (Figure
6B, C). Together, these results show that the reduction of
myosin II activity is sufficient to overcome the non-per-
Matrix rigidity regulates cell surface area in primary oligodendrocytes Figure 3
Matrix rigidity regulates cell surface area in primary oligodendrocytes. (A) Primary oligodendrocytes were cultured 
for 3-4 d on polyacrylamid gels of different rigidities and analyzed for the expansion of myelin membrane sheets by staining for 
MBP (green). Scale bar, 20 μm. (B) The relative sheet size of primary oligodendrocytes was quantified. Values represent the 
mean ± SEM (n > 60 cells, ***p < 0,001).
Chondroitin sulfate proteoglycans reduce cell surface area in Oli-neu cells Figure 4
Chondroitin sulfate proteoglycans reduce cell surface area in Oli-neu cells. (A) Oli-neu cells were cultured for 12 h 
on coverslips coated with different concentrations of chondroitin sulfate proteoglycans (CSPG), stained with Alexa Fluor 488 
conjugated wheat germ agglutinin (WGA) and analyzed for changes in cell surface area. Scale bar, 10 μm. (B) Quantification of 
the surface area of Oli-neu cells cultured on CSPG coated coverslips with or without 10 μM Y27632, C3 transferase or (C) 50 
μM blebbistatin (means ± SEM; n > 80 cells, *p < 0,05, **p < 0,01, ***p < 0,001).BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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Myosin II regulates cell surface area and endocytosis in Oli-neu cells Figure 5
Myosin II regulates cell surface area and endocytosis in Oli-neu cells. (A+B) Western blot analysis of myosin (myo) 
IIA and IIB after siRNA knock down in Oli-neu cells as compared to actin as a loading control. (C) Control siRNA, siRNA 
directed against myosin (myo) IIA, myosin (myo) IIB or both were nucleofected into Oli-neu cells. The cells were subsequently 
cultured on CSPG coated coverslips and changes in cell surface area were quantified after 16 h (means ± SEM; n > 100 cells, 
n.s. not significant, ***p < 0,001). (D) Quantification of dextran uptake (30 min) in Oli-neu cells cultured on CSPG coated cov-
erslips (means ± SEM; n > 100 cells, **p < 0,01, ***p < 0,001). (E) Quantification of dextran endocytosis in Oli-neu cells cul-
tured on CSPG coated or control coverslips and treated with 10 μM Y27632 or 50 μM blebbistatin for 1 h (means ± SEM; n > 
80 cells, *p < 0,05,***p < 0,001). (F) Quantitative analysis of the endocytosis of dextran in Oli-neu cells nucleofected with con-
trol siRNA or siRNA against both myosin IIA and IIB (means ± SEM; n > 80 cells from 2 independent experiments, ***p < 
0,001). Scale bar 20 μm.BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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missive substrate induced inhibition of plasma mem-
brane growth.
Discussion
In this study, we show that cell surface area of oli-
godendrocytes is critically dependent on actomyosin con-
tractility and is regulated by the physical properties of the
supporting matrix. Furthermore, we find that chondroitin
sulfate proteoglycans (CSPG), molecules associated with
non-permissive growth properties within the central nerv-
ous system (CNS), block cell surface spreading. In addi-
tion, we observed that the reductions of plasma
membrane area were accompanied by changes in the rate
of fluid-phase endocytosis. We found that this form of
endocytosis is dependent on actomyosin contractility and
possibly also on integrins. A possible explanation is that
actomyosin contractility pulls membrane into the cell and
thereby accelerates vesicle budding. Loss of integrin-medi-
ated anchoring to the extracellular matrix may increase
these pulling forces of the actin cytoskeleton. We show
that this mechanism is important for cell surface spread-
ing of Oli-neu cells, but it is likely to be involved in the
control of cell surface area in other systems. It may be par-
ticularly relevant in processes where rapid changes of cell
surface area occur, for example in a blood vessel or a blad-
der [27].
Previous work shows that extracellular matrix proteins,
like laminin, promote the formation of myelin membrane
sheets in oligodendrocytes by its interaction with integrin
α6β1 [28,29]. Oligodendrocytes are known to express a
large number of additional integrins including αvβ1,
αvβ3 and α5β5, which may regulate different aspects of
oligodendrocyte biology such as proliferation, differentia-
tion and survival [9,30-34].
In addition to signals from the extracellular matrix, para-
crine signals from oligodendrocytes may also regulate
myelin-membrane extension. Interestingly, the effects of
the CSPG peptide on oligodendrocyte cell surface area
was not observed when cells were grown at a high density,
indicating oligodendrocyte present factors to neighboring
cells that are able to overcome the inhibitory cues.
Integrin-mediated cell attachment is known to regulate
endocytosis and cell surface shape. A striking example of
the importance of this mechanism is the loss of integrin-
mediated adhesion during tumor growth, which triggers
rapid endocytosis and cell rounding [1]. The growth pro-
moting properties of extracellular matrix proteins in oli-
godendrocytes might thus in part be explained by
integrin-mediated retention of membrane at the cell sur-
face. In addition, a role of extracellular matrix proteins in
regulating vesicular traffic within the biosynthetic path-
way to the myelin membrane sheets has been proposed
[35].
The finding that actomyosin contractility acts down-
stream of integrins is consistent with a report describing a
signal transduction pathway from integrins to Fyn that
facilitates RhoA GTPase inactivation and the morpholog-
ical differentiation of oligodendrocytes [10]. Our results
extend this pathway by providing evidence that myosin II
is a downstream target that is regulated by integrins and
Rho/ROCK activity. This concurs with the finding that
myosin II inactivation promotes myelination in the CNS
[36].
In the adult brain OPCs are kept in an undifferentiated
state. This may in part be due to the presence of myelin
from mature oligodendrocytes that blocks their differenti-
ation [37]. Whether this occurs by Rho/ROCK/myosin II
activation is an interesting question for future research.
After demyelination OPCs are recruited to the site of the
lesion where they differentiate. In multiple sclerosis remy-
elination can be extensive, however, OPC frequently fail
to differentiate [38-41]. The inhibitory cues for OPCs in
multiple sclerosis lesions have not been identified, but
upregulation of growth inhibiting molecules such as
CSPG within the glial scar is one possibility.
We do not know by what means CSPGs affects cell surface
size, but the finding that knocking down myosin II over-
comes CSPGs inhibitory effects points to a role of actomy-
osin contractility in this process. Earlier work examining
the role of CSPGs on axon outgrowth suggested that
CSPGs interfere with extracellular matrix/integrin interac-
tions [42].
Indeed, increased integrin expression is sufficient to elim-
inate the inhibitory effects of CSPGs on neuronal growth
cone function [43]. A down-stream role of the Rho/ROCK
signalling system has also been identified [25].
Our results demonstrating that inhibition of Rho/ROCK/
myosin II activity is able to overcome a non-permissive
growth property of the extracellular environment on oli-
godendrocytes extends the role of this system in cellular
regeneration.
These findings not only show that the actomyosin system
plays a role in cell surface spreading of oligodendrocytes,
but also point to potential target for therapeutic interven-
tions. However, we do not yet know whether the inhibi-
tion of actomyosin contractility affects the ability of
oligodendrocytes to wrap their plasma membrane around
an axon to form compact myelin. Clearly, in vivo studies
are now required to determine whether inhibition of acto-
myosin contractility promotes myelin repair in the CNS.BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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Conclusion
In summary, we find that cell surface area depends on
actomyosin contractility and is regulated by physical
properties of the supporting matrix. CSPG blocks cell sur-
face spreading, but the inhibitory effect of CSPG on
plasma membrane extension is prevented by treatment
with inhibitors of actomyosin contractility and by RNAi
mediated knockdown of myosin II. These results establish
a novel connection between cell surface extension and
actomyosin contractility in oligodendrocytes and open up
new possibilities of how to promote the morphological
differentiation of oligodendrocytes in a non-permissive
growth environment.
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Inhibition of Myosin II promotes spreading of myelin-membrane sheets on CSPG Figure 6
Inhibition of Myosin II promotes spreading of myelin-membrane sheets on CSPG. (A) Primary oligodendrocytes 
were cultured on CSPG coated or control coverslips treated with 10 μM Y27632 or 50 μM blebbistatin 2 h after seeding, 
stained for MBP and analyzed for changes in the size of myelin membrane sheets. Changes in cell surface area were quantified 
after 2-3 days. Values represent means ± SEM (n > 60 cells, n.s. not significant, ***p < 0,001). (B, C) Primary oligodendrocytes 
were nucleofected with siRNA directed against both myosin (myo) IIA and IIB or control (Ctrl) siRNA. The cells were subse-
quently cultured on CSPG coated or control coverslips and membrane sheet size was analyzed after 3 d. (C) Quantitative anal-
ysis of membrane sheet size (means ± SEM; n > 30 cells, *p < 0,05). (B) Primary oligodendrocytes stained with O1 antibody to 
visualize membrane sheets. Scale bar 20 μm.BMC Cell Biology 2009, 10:71 http://www.biomedcentral.com/1471-2121/10/71
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